Impairment Testing

An impairment test is an accounting review to determine whether an asset (tangible or intangible) has suffered a permanent decline in value requiring recognition of a loss on the income statement. If the asset’s carrying value (book value) exceeds its recoverable amount—either the fair value (from sale) or value in use (from future cash flows)—the asset is impaired and must be written down. Impairment testing is mandatory for goodwill, intangible assets, and long-lived assets when indicators suggest decline.

The mechanics of impairment testing

Impairment testing assesses whether the recorded value of an asset (its “carrying amount” or “book value”) is supported by its true economic value—what the asset could be sold for or the cash it is expected to generate. If the economic value has fallen below the book value, the company must recognize an impairment loss.

The process differs by asset type:

Goodwill and indefinite-life intangibles: These are tested annually (or more frequently if indicators of decline appear). The test is typically a “fair value test”—the company estimates the fair value of the business unit (or reporting unit) that includes the goodwill. If the fair value is below the carrying value of the unit (which includes goodwill), goodwill is impaired. The impairment charge is the excess of goodwill’s carrying value over its implied value (calculated as fair value of unit minus other assets and liabilities).

Finite-life intangible assets (patents, customer relationships, software): These are tested if indicators of impairment exist (e.g., loss of a major customer, expiration of a patent, technology obsolescence). The test compares carrying value to expected undiscounted cash flows over the asset’s remaining life. If the carrying value exceeds undiscounted cash flows, impairment is probable and is measured as the difference between carrying value and the discounted value of future cash flows (present value).

Tangible assets (land, buildings, equipment): These are tested if events suggest impairment (decline in market value, obsolescence, significant underutilization). Similar to intangibles, the asset’s recoverable amount is compared to book value, and impairment is measured as the shortfall.

Why impairment matters

Impairment recognition has several important consequences:

Income statement impact: The impairment charge reduces earnings in the period in which the impairment is recognized. A large goodwill impairment can swing a profitable company to a loss. For example, AOL’s $99 billion goodwill impairment charge (2009, in connection with the failed Time Warner merger) reduced earnings by tens of billions and was one of the largest write-downs in history.

Balance sheet impact: The asset value is written down, reducing total assets and equity (since the loss reduces retained earnings).

Tax and regulatory effects: Depending on jurisdiction, impairment may be deductible or nondeductible for tax purposes. A nondeductible impairment creates a timing difference (book loss this year, no tax deduction, affecting deferred tax assets).

Covenant and credit triggers: Debt covenants often use net worth or leverage ratios tied to GAAP earnings and assets. A large impairment can trigger covenant violations and accelerate debt repayment.

Investor and analyst perception: Impairments signal that management’s prior investment (often via M&A) was flawed. Repeated impairments damage credibility. Analysts scrutinize impairments as evidence that the company overpaid for acquisitions or that business conditions have deteriorated.

Goodwill impairment: A history of accounting change

Goodwill has been historically fraught. Before the 1980s, companies had to amortize goodwill over a period (usually 20–40 years), which reduced earnings gradually. In the 1980s, FASB changed the rule: goodwill acquired in a merger could be recorded on the balance sheet and was no longer amortized—instead, it was tested annually for impairment.

The intent was to allow “fair value” accounting: if the business retained its value, no impairment; if value fell, companies would write it down. In practice, the policy created perverse incentives:

• Companies could record very large goodwill amounts in M&A deals (purchase price minus fair value of identifiable assets), reducing reported earnings only if the deal truly failed. Moderately unsuccessful deals (where the acquired business underperformed but was not catastrophic) could avoid impairment for years.
• Impairment testing was subjective, relying on management’s cash flow projections. Optimistic projections delayed impairments.
• The big-bath phenomenon: in restructuring years (e.g., after a new CEO) or bad years, companies would record massive impairments, clearing the balance sheet and resetting the baseline.

After 2008, when the recession revealed hundreds of billions in overpaid acquisitions, regulators and investors called for stricter impairment testing. FASB simplified goodwill testing in 2017: companies no longer had to step-test goodwill (a two-step process comparing fair values); instead, they directly compare the fair value of a reporting unit to its carrying value (including goodwill). If fair value is below carrying value, goodwill is impaired.

Valuation methods in impairment testing

The core of impairment testing is estimating the asset’s recoverable amount, typically via:

Discounted cash flow (DCF): Project future cash flows from the asset (or business unit) and discount them to present value using an appropriate discount rate. If the DCF is below carrying value, impairment is the difference. DCF is theoretically sound but highly dependent on cash flow assumptions and discount rate, both of which are subjective.

Market comparables: Estimate fair value using multiples from similar assets or companies (e.g., a business unit’s value via EV/EBITDA multiples from peer companies). This is objective if comparable data is available but may be unreliable in illiquid markets.

Recent transactions: If a similar asset sold recently, use the transaction price as a benchmark for fair value. This is reliable if transactions are truly comparable and recent.

Expert appraisal: For specialized assets (real estate, mines, specialized equipment), hire an appraiser to estimate fair value. This is costly but reduces bias.

Most companies use a blended approach, weighting multiple methods based on reliability of data.

Practical challenges

Timing of impairment recognition: Companies are incentivized to delay recognition (to maintain reported earnings) but also to bunch impairments in already-bad years (big-bath accounting). Auditors and regulators scrutinize the timing to ensure impartiality.

Management bias: Management projects cash flows; optimism bias can inflate projections and delay impairment recognition. Auditors push back on aggressive assumptions.

Reasonableness of assumptions: A DCF with a 2% long-term growth rate may be reasonable for a utility but aggressive for a cyclical manufacturer. Auditors verify that assumptions are industry-appropriate.

Currency and interest rate assumptions: For multinational companies, impairment testing is sensitive to exchange rates and discount rates; changes in macro conditions can flip a non-impaired asset into impaired status.

Disclosure requirements

Under IFRS and GAAP, companies must disclose:

• The nature and amount of impairment charges (usually in footnotes to financial statements).
• For significant impairments, the events that triggered testing and the assumptions used (cash flow growth rates, discount rates).
• Sensitivity to key assumptions: “If the discount rate were 1% higher, goodwill would be impaired by $X million.”

This disclosure allows investors to assess the robustness of management’s valuations and to challenge assumptions they find unreasonable.